XWELL Inc (XWEL)
1.73
+0.03
(+1.76%)
USD |
NASDAQ |
Oct 04, 16:00
1.705
-0.02
(-1.45%)
After-Hours: 20:00
XWELL Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2015 | 0.092M |
| December 31, 2014 | |
| December 31, 2013 | 1.512M |
| December 31, 2012 | 0.543M |
| Date | Value |
|---|---|
| December 31, 2011 | 2.017M |
| December 31, 2010 | 2.503M |
| December 31, 2009 | 1.975M |
| December 31, 2008 | 3.11M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Fonar Corp | 1.736M |
| ProPhase Labs Inc | 1.418M |
| Applied DNA Sciences Inc | 3.735M |
| Veracyte Inc | 57.30M |
| OncoCyte Corp | 9.294M |